Interviews

Charles Bennett, MD, PhD, Discusses the FDA’s Biosimilar Approval Timeline

January 13, 2021

Video

Charles Bennett, MD, PhD, a hematologist and oncologist and professor in the Clinical Pharmacy and Outcomes Sciences Department of the College of Pharmacy at the University of South Carolina, discussed the FDA’s pace of biosimilar approvals and the findings from his recent study.

Part 2: Ivo Abraham, PhD, RN, Discusses the Pandemic’s Effect on Pegfilgrastim Biosimilar Use

January 5, 2021

Video

Ivo Abraham, PhD, RN, a professor with the University of Arizona Health Sciences in the Department of Pharmacy Practice and a health care consultant and co-founder of Matrix45, discussed how the pandemic is likely to impact the use of pegfilgrastim biosimilars.

The Most-Popular Center for Biosimilars® Interviews of 2020

December 26, 2020

Video

Here are some of our most-popular biosimilar interviews for all of 2020.

Part 1: Ivo Abraham Talks About Biosimilar Pegfilgrastim Savings Amid COVID-19

December 21, 2020

Video

Ivo Abraham, PhD, RN, a professor in the Department of Pharmacy Practice at University of Arizona Health Sciences, and a health care consultant with Matrix45, discusses recent studies that demonstrated savings for pegfilgrastim vs the on-body injector.

Jennifer Snow on Most-Favored Nation and Other Pricing Reforms

December 14, 2020

Video

We sat down with Jennifer Snow, MPH, vice president of Reimbursement and Policy Insights at Xcenda, to talk about health care reform efforts and how these would be affected by the change in administration.

Robert Rifkin, MD, Discusses Overcoming Lingering Biosimilar Education Gaps

December 5, 2020

Video

Robert Rifkin, MD, FACP, oncologist and hematologist with Rocky Mountain Cancer Centers and medical director of Biosimilars for McKesson, discusses how his practice is working to correct biosimilar education gaps among physicians and the consequences if those gaps are not addressed.

Part 2: Jorge Garcia on Giving Pharmacists Latitude to Switch to Biosimilars

November 25, 2020

Video

Jorge Garcia, PharmD, MS, MHA, MBA, assistant vice president of the System Oncology Pharmacy Service Line at Baptist Health South Florida, discussed how Baptist Health increases biosimilar use and how innovator companies fight to avoid biosimilar competition.

Jorge Garcia Talks About COVID-19’s Effect on Pegfilgrastim Biosimilars

November 18, 2020

Video

Jorge Garcia, MS, assistant vice president of the System Oncology Pharmacy Service Line at Baptist Health South Florida, discussed how the pandemic has interrupted oncology care for patients and affected the utilization of pegfilgrastim biosimilars.

Part 2: Nabeel Khan, MD, Discusses the Significance of a VA Study on Biosimilar Switching

November 7, 2020

Video

Nabeel Khan, MD, an associate professor of clinical medicine with the University of Pennsylvania, explains how a recent infliximab switching study builds support for use of biosimilars and early treatment with these agents.

Part 1: Nabeel Khan, MD, Discusses an Infliximab Double-Switching Study

November 4, 2020

Video

Nabeel Khan, MD, an associate professor of clinical medicine with the University of Pennsylvania, discussed a study in which patients were switched from reference and biosimilar forms of infliximab to another biosimilar infliximab, Renflexis.

x